Investor Overview
![]() |
Webcast
AtriCure to Participate at the Oppenheimer 31st Annual Healthcare Conference
03/16/21 1:10 PM EDT
|
![]() |
Webcast
AtriCure at the SVB Leerink 10th Annual Global Healthcare Conference
02/24/21 8:00 AM EST
|
![]() |
Webcast
Q4 and Full Year 2020 AtriCure, Inc. Earnings Conference Call
02/23/21 4:30 PM EST
|
![]() |
Webcast
AtriCure at the 39th Annual J.P. Morgan Healthcare Conference
01/11/21 7:30 AM EST
|
Corporate Profile
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.
Stock Quote
(Common) | |||
Price | Change | % Change | Volume |
Previous Close | Today's Open | Intraday High | Intraday Low |
Exchange: (US Dollar) | |||
Mar 5, 2021 11:42 AM EST |
Featured Reports
Date | Title |
---|---|
02/26/21
|
2020 Annual Report 1.3 MB
|
01/11/21
|
|
05/08/20
|
|
08/12/19
|
Acquisition of SentreHEART Overview 778.9 KB
|
More News >>
Events
Date | Title |
---|---|
03/16/21 1:10 PM EDT
|
More Events >>